Here are comprehensive, exam-ready answers for all 14 questions (Q17–Q30):
Q17. Etiopathogenesis of Thyroidal Swellings
Classification
| Category | Examples |
|---|
| Non-toxic diffuse | Simple/endemic goitre, physiological goitre |
| Non-toxic nodular | Multinodular goitre, follicular adenoma |
| Toxic | Graves' disease, toxic MNG, toxic adenoma |
| Inflammatory | Hashimoto's, de Quervain's, Riedel's thyroiditis |
| Neoplastic | Adenoma, carcinomas |
A. Diffuse & Multinodular Goitre
Core Pathogenetic Mechanism:
- ↓ iodine intake → impaired T₃/T₄ synthesis
- ↓ T₃/T₄ → compensatory ↑ TSH
- ↑ TSH → hypertrophy and hyperplasia of follicular cells
- Recurrent cycles → irregular multinodular goitre with fibrosis, hemorrhage, calcification
Endemic goitre — dietary iodine deficiency; "endemic" when >10% of population affected
Sporadic goitre — females > males; causes: goitrogenic foods (cruciferous vegetables), dyshormonogenesis (enzyme defects), drugs (lithium, iodides)
B. Autoimmune Thyroid Diseases
Graves' Disease (Toxic Diffuse Goitre)
- Most common cause of hyperthyroidism (85%)
- Pathogenesis: IgG autoantibodies (TSI) bind and stimulate TSH receptor → unregulated T₃/T₄ production
- Ophthalmopathy: TSH receptors on orbital fibroblasts → T-cell cytokines → retroorbital tissue expansion
- Morphology: Symmetrical enlargement, tall columnar epithelium, papillary projections, scalloped colloid, lymphoid follicles
Hashimoto Thyroiditis (Most common hypothyroidism cause)
- Female:Male = 10–20:1
- Pathogenesis: CD8+ cytotoxic T cells destroy thyroid epithelium; anti-TPO and anti-thyroglobulin antibodies (complement-mediated)
- Morphology: Lymphocytic infiltrate with germinal centres, Hürthle cell metaplasia, follicular atrophy
Subacute (de Quervain's) Thyroiditis — post-viral granulomatous inflammation; transient hyperthyroidism → hypothyroidism
Riedel's Thyroiditis — IgG4-related disease; dense fibrosis, "woody" hard fixed gland simulating malignancy
C. Thyroid Neoplasms
| Type | Frequency | Key Mutation | Feature |
|---|
| Papillary | >85% | BRAF, RET/NTRK | Ground-glass nuclei, psammoma bodies, excellent prognosis |
| Follicular | 5–15% | RAS, PAX8-PPARG | Capsular/vascular invasion; no papillary nuclei |
| Anaplastic | <5% | TP53 | Highly aggressive, older patients |
| Medullary | 5% | RET (MEN2) | C-cell origin; calcitonin-secreting; amyloid deposits |
Risk factors for malignancy in a nodule: solitary, male, age <30, history of irradiation, "cold" nodule, rapid growth, hoarseness
Q18. Applied Anatomy of Parathyroid
General
- Number: Usually 4 (2 superior, 2 inferior); 5% have >4 glands
- Weight: 30–50 mg each
- Colour: Yellow-tan-brown (brighter yellow fat helps distinguish them intraoperatively)
Embryology
| Gland | Origin | Migration |
|---|
| Superior | 4th branchial pouch | Short — less variable position |
| Inferior | 3rd branchial pouch (with thymus) | Long — more variable position |
Surgical Positions
Superior parathyroids: Level of the cricothyroid articulation; ~1 cm above ITA–RLN crossing; posterolateral to superior thyroid pole; DORSAL (deep) to RLN
Inferior parathyroids: Near inferior pole of thyroid; associated with thyrothymic ligament; VENTRAL (superficial) to RLN
Key surgical rule: Superior = dorsal to RLN; Inferior = ventral to RLN
Ectopic Sites
Retroesophageal, anterior mediastinum (most common ectopic site), intrathyroidal, carotid sheath, along thyrothymic ligament
Blood Supply
- Both glands primarily supplied by inferior thyroid artery (branch of thyrocervical trunk)
- 10% of inferior glands supplied by superior thyroid artery branch
- Right adrenal vein → IVC directly; rich anastomotic network protects against ischaemia
Histology
- Chief cells — small, pale; secrete PTH
- Oxyphil cells — large, eosinophilic; rich in mitochondria; function uncertain
- Fat content increases with age
Surgical Significance
- Transient hypoparathyroidism: up to 20% after total thyroidectomy
- Permanent hypoparathyroidism: ~5% after adenoma surgery
- Inadvertently removed tissue → autotransplantation into sternocleidomastoid or brachioradialis
- Intraoperative PTH assay confirms adequate resection (>50% fall in PTH)
Q19. Clinical Features of Hypo- and Hyperparathyroidism and Management
A. HYPERPARATHYROIDISM
Types
- Primary HPT: Autonomous PTH overproduction (adenoma 85–95%, hyperplasia 5–10%, carcinoma 1%)
- Secondary HPT: Compensatory — chronic renal failure → hypocalcaemia → ↑ PTH
- Tertiary HPT: Secondary HPT becomes autonomous with hypercalcaemia
Clinical Features — Mnemonic: "Bones, Stones, Groans, Psychic Moans"
| System | Features |
|---|
| Bones | Osteitis fibrosa cystica; subperiosteal resorption; "brown tumours"; pathological fractures |
| Stones | Nephrolithiasis (calcium oxalate/phosphate); nephrocalcinosis; polyuria/polydipsia |
| Groans | Constipation, nausea, peptic ulcers (↑ gastrin), pancreatitis |
| Psychic Moans | Depression, lethargy, confusion, psychosis; proximal muscle weakness |
| CVS | Hypertension, shortened QT interval, arrhythmias |
Labs: ↑ Ca²⁺, ↑ PTH (inappropriately elevated), ↓ phosphate, ↑ urinary Ca²⁺, ↑ ALP
Most common cause of asymptomatic hypercalcaemia = Primary HPT; Most common cause of symptomatic hypercalcaemia = Malignancy
Management — Hyperparathyroidism
Acute Hypercalcaemic Crisis:
- IV normal saline (↑ urinary calcium excretion)
- Loop diuretics (furosemide) — inhibit renal calcium reabsorption
- Bisphosphonates (zoledronic acid/pamidronate) — inhibit osteoclasts
- Calcitonin — rapid ↓ Ca²⁺ within hours
- Dialysis in renal failure
Surgery (Parathyroidectomy) — Definitive treatment:
Indications in asymptomatic primary HPT:
- Serum Ca²⁺ >1 mg/dL above upper limit of normal
- 24h urine Ca²⁺ >400 mg/day
- T-score ≤ −2.5 (osteoporosis)
- Age <50 years
- Creatinine clearance <60 mL/min
Intraoperative PTH must drop >50% to confirm adequate resection.
B. HYPOPARATHYROIDISM
Causes
- Post-surgical — most common (inadvertent removal during thyroidectomy/neck dissection)
- Autoimmune — AIRE gene mutations (APS type 1)
- Congenital — DiGeorge syndrome (22q11.2 deletion — absent parathyroids + thymus + cardiac defects)
- Hypomagnesaemia — functional hypoparathyroidism
Clinical Features (all from hypocalcaemia)
Acute:
- Perioral and fingertip tingling/paraesthesiae
- Carpopedal spasm / tetany
- Facial grimacing
- Seizures, cardiac arrhythmias
Chronic:
- Cataracts
- Basal ganglia calcification (Fahr's disease)
- Dental abnormalities, papilloedema
Special signs:
- Chvostek's sign: Tapping facial nerve → ipsilateral facial muscle twitch
- Trousseau's sign: BP cuff inflation → carpopedal spasm (more specific)
- ECG: Prolonged QT interval
Labs: ↓ Ca²⁺, ↑ phosphate, ↓ PTH, ↓ urinary Ca²⁺
Management — Hypoparathyroidism
| Setting | Treatment |
|---|
| Acute symptomatic tetany | IV calcium gluconate 10 mL of 10% solution slowly; monitor ECG |
| Chronic maintenance | Oral calcium carbonate 1–2 g/day + Calcitriol 0.25–2 μg/day |
| Target serum Ca²⁺ | Low-normal range (8–8.5 mg/dL) to prevent hypercalciuria and renal stones |
| Refractory cases | Recombinant PTH (teriparatide) |
Q20. Applied Anatomy of Adrenal Gland
General
| Feature | Details |
|---|
| Number | Paired, retroperitoneal; within Gerota's fascia |
| Position | Level of 11th–12th ribs; superior to upper kidney poles |
| Weight | 4–5 g each |
| Shape | Right = triangular; Left = crescent-shaped |
Anatomical Relations
| Side | Key Relations |
|---|
| Right adrenal | Medially: IVC; Anteriorly: liver; Posteriorly: right crus of diaphragm |
| Left adrenal | Medially: aorta; Anteriorly: stomach, pancreas, splenic vessels; Posteriorly: left crus |
Blood Supply
Arterial (triple supply):
- Superior adrenal arteries — from inferior phrenic arteries
- Middle adrenal arteries — direct from aorta
- Inferior adrenal arteries — from ipsilateral renal artery
Venous (predictable — surgical key):
| Side | Vein | Drains into |
|---|
| Right | Short right adrenal vein | IVC directly (posterior wall) |
| Left | Long left adrenal vein (+ inferior phrenic vein) | Left renal vein |
⚠️ The short right adrenal vein is the most dangerous structure in right adrenalectomy — risk of IVC avulsion
Lymphatics
- Right → paracaval nodes
- Left → para-aortic nodes
Innervation
- Medulla: Direct preganglionic sympathetic fibres (unique — chromaffin cells = modified sympathetic neurons)
- Cortex: Postganglionic splanchnic fibres
Embryology
| Component | Origin |
|---|
| Cortex | Intermediate mesoderm (urogenital ridge) — mesodermal |
| Medulla | Neural crest cells (neuroectodermal) |
Cortical Zones — Mnemonic: GFR = ACE
| Zone | Product |
|---|
| Glomerulosa (outer) | Aldosterone (mineralocorticoid) — RAA system |
| Fasciculata (middle) | Cortisol (glucocorticoid) — HPA axis |
| Reticularis (inner) | Estrogens/androgens (DHEA) — sex steroids |
Medulla: Chromaffin cells → epinephrine (80%), norepinephrine (20%)
Surgical Significance
- Pheochromocytoma: 10% bilateral, 10% extra-adrenal (paraganglioma), 10% malignant ("Rule of 10s")
- Adrenal incidentaloma: 1–4% of abdominal CT scans
- Laparoscopic adrenalectomy: lateral transabdominal or posterior retroperitoneoscopic approach
Q21. Planning and Conduct of Surgical Audit
Definition
A systematic, cyclical review of surgical care processes and outcomes against defined standards, with implementation of improvements — completing the audit cycle.
A. Planning the Audit
1. Define Scope & Purpose
- Choose procedure/condition (e.g., appendicectomy, thyroidectomy)
- Define whether it is a process audit (was care delivered correctly?) or outcome audit (what were the results?), or both
- Set time period and eligible patient population
2. Establish Standards
- Evidence-based guidelines (ERAS, WHO Safe Surgery Checklist, NICE guidelines)
- Measurable indicators:
- Process: antibiotic prophylaxis timing, VTE prophylaxis, normothermia
- Outcome: 30-day morbidity/mortality, wound infection rate, readmission rate, length of stay
3. Assemble Multidisciplinary Team
- Surgeon, anaesthesiologist, nurses (ward + OR), pharmacist, physiotherapist, administrator/audit coordinator
4. Data Collection Method
- Prospective > retrospective
- Use standardised tools: ACS-NSQIP, ERAS Interactive Audit Tool, WHO surgical safety checklist
- Define key variables: patient demographics, ASA grade, comorbidities, operative details, postoperative outcomes
B. Conduct of the Audit
Step 1: Data Collection
- All eligible cases; trained data abstractor reviews records
- NSQIP: 8-day sampling blocks; 30-day outcome follow-up
Step 2: Risk Adjustment
- Use observed-to-expected (O:E) ratio via multivariate logistic regression
- Prevents penalising high-acuity centres
Step 3: Benchmarking
- Compare against peer institutions, national standards, or own previous performance (temporal trends)
Step 4: Feedback
- Share results openly with all stakeholders
- Regular multidisciplinary review meetings (monthly/quarterly)
Step 5: Root Cause Analysis
- Identify system errors (most common) vs. provider errors
- Develop targeted improvement interventions
Step 6: Re-Audit (Complete the Cycle)
- Repeat after implementing changes to assess whether improvements are sustained
Key Quality Frameworks
| Programme | Impact |
|---|
| ACS-NSQIP | 31% ↓ 30-day mortality in first decade; 82% of hospitals decreased complications |
| WHO Safe Surgery Checklist | Sign-in → Time-out → Sign-out; reduces preventable surgical deaths |
| ERAS | >80% compliance → ~50% reduction in complication rates in colorectal surgery |
| SCIP | SSI prevention, VTE, cardiac event measures |
Surgical "Never Events"
- Wrong site/wrong patient/wrong procedure surgery
- Retained foreign object
- Postoperative death after elective low-mortality procedure
Q22. Tissue Injuries and Their Management
Phases of Wound Healing
Haemostasis → Inflammation → Proliferation → Remodelling
Phase 1: Haemostasis (Minutes)
- Vascular injury → vasoconstriction → platelet aggregation → fibrin clot
- Platelets release PDGF, TGF-β, EGF → initiate cascade
- Provisional fibrin matrix = scaffold for cell migration
Phase 2: Inflammation (Hours – Day 4)
| Cell | Peak | Function |
|---|
| Neutrophils | Day 2 | First responders; phagocytosis; ROS, proteases to clear bacteria |
| Macrophages | Day 3 | "Orchestrators"; phagocytosis; secrete PDGF, VEGF, TGF-β, FGF |
| Lymphocytes | Day 7 | Modulate repair |
Phase 3: Proliferative (Day 3 – Week 3)
- Granulation tissue = capillary bed + fibroblasts + macrophages + loose collagen + fibronectin
- Angiogenesis (VEGF-driven)
- Fibroplasia: fibroblasts synthesise type III collagen (later replaced by type I)
- Epithelialisation: keratinocyte migration
Phase 4: Remodelling (Week 3 – 1 Year)
- Fibroblasts → myofibroblasts → wound contraction
- Type III collagen → cross-linked type I collagen
- Maximum tensile strength = only 70–80% of unwounded skin (never 100%)
Abnormal Wound Healing
Hypertrophic Scar vs. Keloid
| Feature | Hypertrophic Scar | Keloid |
|---|
| Extent | Within wound borders | Beyond wound borders |
| Regression | Often spontaneous | Rarely regresses |
| Genetics | No predisposition | Strong genetic basis; African/Asian descent |
| Sites | Areas of tension (back, chest) | Earlobes, shoulders, sternum |
| Recurrence after excision | Low | High (50–100%) |
Chronic Wounds
- Fail to progress within 3 months
- Stuck in inflammatory phase; high MMP activity, ↓ growth factors, ↑ bacterial load
- Types: diabetic foot ulcers, venous leg ulcers, pressure ulcers
Factors Impairing Wound Healing
| Intrinsic | Extrinsic |
|---|
| Age | Hypoxia/ischaemia |
| Diabetes mellitus | Infection |
| Malnutrition | Ionising radiation |
| Cardiovascular disease | Smoking (30–40% ↓ wound blood flow) |
| Genetic disorders | Glucocorticoids, cytotoxics |
| Vitamin C/A deficiency; zinc deficiency |
Management
Acute Wounds:
- Haemostasis (pressure, ligation, cautery)
- Wound cleansing — saline irrigation, debridement
- Closure:
- Primary intention — immediate closure (clean wounds, <6 h)
- Delayed primary — closure at 4–5 days (contaminated)
- Secondary intention — granulation (infected/large wounds)
- Tetanus prophylaxis
- Antibiotics only if infected
Chronic Wounds:
- Treat underlying cause (glycaemic control, compression therapy, pressure relief)
- Wound bed preparation — debridement, moisture balance, infection control
- Appropriate dressings (hydrocolloids, foam, silver-impregnated)
- Advanced therapies: PDGF (becaplermin), negative pressure wound therapy (VAC), hyperbaric oxygen, skin grafts
Keloids/Hypertrophic Scars:
- Silicone sheeting + pressure garments (prevention/first line)
- Intralesional triamcinolone acetonide (10–40 mg/mL every 2–4 weeks)
- 5-Fluorouracil intralesional injections
- Keloid excision + immediate radiation → <10% recurrence
Q23. Biohazard and Hospital Waste — Appropriate Methods of Disposal
Classification of Hospital Waste (WHO/CPCB)
| Category | Examples | Colour Code | Disposal Method |
|---|
| Infectious/Pathological | Body parts, blood-soaked dressings, cultures | Yellow bag | Incineration (gold standard) or deep burial |
| Sharps | Needles, scalpels, broken glass | White/Blue puncture-proof container → Yellow bag | Incineration after safe containment |
| Microbiological | Lab cultures, vaccines, live blood products | Red bag | Autoclaving (steam sterilisation), then landfill |
| General (non-hazardous) | Paper, packaging, office waste | Black bag | Municipal landfill |
| Chemical/Pharmaceutical | Expired drugs, cytotoxics, chemicals | Brown/Yellow | Specialist chemical incineration/return to manufacturer |
| Radioactive | Nuclear medicine waste | Lead containers | Licensed storage & disposal by radiation authority |
Key Principles
- Segregation at source — colour-coded bags/bins at the point of generation
- Never overfill bags (>¾ full)
- Labelling — generator identity, date, category on all bags
- Safe handling — PPE (gloves, aprons, face shields) for handlers
- Transport — designated routes; covered trolleys; no hand-carrying of sharps
- Record keeping — waste manifest system (chain of custody)
Disposal Methods
Incineration (gold standard for Category I — infectious/anatomical):
- High-temperature two-chamber incinerators (850–1100°C)
- Destroys pathogens, reduces volume by 90%
- Produces toxic dioxins/furans → requires gas scrubbers
Autoclaving (Steam Sterilisation):
- 134°C at 2 bar for 18 min (or 121°C for 30 min)
- For microbiological waste (Category II)
- After autoclaving → treated waste can go to landfill
Chemical Disinfection:
- Liquid chemical waste and effluents
- Hypochlorite, glutaraldehyde
- Not for solid waste
Sharps Protocol:
- Never recap needles (one-handed scoop if necessary)
- Puncture-proof containers; fill to ¾ only
- Sealed containers → incineration
Cytotoxic Waste:
- Separate high-temperature incineration (>1000°C)
- Never with general infectious waste
Q24. Principles of Ethics in General Surgery
Four Pillars of Medical Ethics (Beauchamp & Childress)
| Principle | Application in Surgery |
|---|
| Autonomy | Patient's right to make informed decisions about their own care; valid informed consent required |
| Beneficence | Acting in the patient's best interest; choosing treatments with best evidence of benefit |
| Non-maleficence | "First, do no harm" — avoid unnecessary operations, minimise complication risk |
| Justice | Fair allocation of healthcare resources; non-discrimination |
Informed Consent
Four essential elements (VIVA):
- Voluntariness — free of coercion or undue influence
- Information — procedure, alternatives, risks, benefits explained in understandable language
- Capacity — patient must have the mental capacity to understand, retain and weigh information
- Authorisation — explicit agreement (verbal or written)
Exceptions to informed consent:
- Emergency/life-threatening situations
- Waiver by patient
- Therapeutic privilege (very rarely applicable)
Specific Ethical Issues in Surgery
Advance Directives / Living Wills: Patient's pre-expressed wishes about care if they lose capacity; must be respected
DNR (Do-Not-Resuscitate) Orders:
- Requires discussion with patient/family
- Does not mean "do not treat" — only cardiac arrest; full palliative/comfort care continues
Principle of Double Effect:
- Giving adequate analgesia/sedation knowing it may hasten death is ethically permissible if the intent is relief of suffering, not death
Futile Treatment:
- Surgeons are not obligated to provide treatment that will not benefit the patient
- Requires open, compassionate communication with patient/family
Confidentiality:
- Patient information must not be disclosed without consent
- Exceptions: Public health reporting (infectious diseases), court orders, imminent risk to others
Disclosure of Errors:
- Ethical obligation to disclose errors (even near-misses) transparently
- "Never events" must be disclosed and investigated
Specific Surgical Ethics Scenarios
| Scenario | Ethical Principle |
|---|
| Jehovah's Witness refusing blood transfusion | Respect autonomy (competent adult); proceed without transfusion; document |
| Incidental finding during surgery | Disclose; obtain consent before additional intervention unless life-threatening |
| Operative complications | Full disclosure; duty of candour |
| Resource scarcity (organ allocation, ICU beds) | Justice; use fair allocation criteria |
| Surrogate decision-making | Best-interest standard; hierarchy of surrogates |
Q25. Anaesthesia and Pain Management
Types of Anaesthesia
| Type | Description | Use |
|---|
| General Anaesthesia (GA) | Total loss of consciousness and sensation; requires airway management | Major surgery |
| Regional Anaesthesia | Blocks nerve conduction in specific area; patient awake | Limb/regional surgery |
| Monitored Anaesthetic Care (MAC) | Sedation + local; patient responsive | Minor procedures |
| Local Anaesthesia | Topical/infiltration at surgical site | Minor procedures |
General Anaesthesia — Components (TRIAD)
- Hypnosis (unconsciousness) — inhalational/IV agents
- Analgesia — opioids, NSAIDs, ketamine
- Muscle relaxation — NMBs
Inhalational Agents
- Volatile agents: Isoflurane, sevoflurane, desflurane
- MAC (Minimum Alveolar Concentration): Concentration required to prevent movement in 50% of patients in response to surgical incision (standard measure of potency)
- Nitrous oxide (N₂O): Weak anaesthetic; used as carrier gas; analgesic
Intravenous Agents
| Drug | Features |
|---|
| Propofol | Most common induction agent; rapid onset/offset; antiemetic; causes ↓ BP |
| Ketamine | Dissociative anaesthesia; bronchodilator; preserves airway reflexes; ↑ BP/HR — ideal for haemodynamically compromised patients |
| Etomidate | Haemodynamically stable; suppresses adrenal cortex (single dose) — use in trauma |
| Thiopentone | Barbiturate; rapid induction; cerebral protection |
| Midazolam | Benzodiazepine; anxiolysis, amnesia, anticonvulsant |
Neuromuscular Blocking Drugs (NMBs)
| Drug | Type | Reversal |
|---|
| Succinylcholine | Depolarising (ACh receptor agonist — sustained depolarisation) | Spontaneous (pseudocholinesterase) |
| Rocuronium | Non-depolarising (competitive antagonist) | Sugammadex (encapsulates) |
| Atracurium | Non-depolarising | Neostigmine + glycopyrrolate |
Succinylcholine contraindicated in burns (>48h), denervation injuries, hyperkalaemia risk
Regional Anaesthesia
| Technique | Details |
|---|
| Spinal (subarachnoid block) | LA injected into CSF at L3/L4 or L4/L5; below conus medullaris (L1–L2); rapid dense block |
| Epidural | LA into epidural space; catheter for continuous infusion; used in labour, post-op analgesia |
| Brachial plexus block | Interscalene, supraclavicular, infraclavicular, axillary — upper limb surgery |
| Femoral/sciatic nerve blocks | Lower limb surgery and analgesia |
Pain Management
WHO Analgesic Ladder (3 Steps)
- Mild pain: Non-opioids (paracetamol, NSAIDs)
- Moderate pain: Weak opioids (codeine, tramadol) + non-opioids
- Severe pain: Strong opioids (morphine, fentanyl, oxycodone) + non-opioids
Multimodal Analgesia (Gold Standard in Postoperative Pain)
Combining agents from different classes to achieve synergistic analgesia with reduced side effects:
- Paracetamol (regular, around the clock)
- NSAIDs/COX-2 inhibitors (unless contraindicated)
- Gabapentinoids (gabapentin/pregabalin — preoperative and postoperative)
- Ketamine low-dose infusion (opioid-sparing, especially in chronic pain/opioid tolerance)
- Regional anaesthesia (nerve blocks, epidural)
- Opioids (for breakthrough/rescue only)
Acute Pain Service (APS)
- Dedicated team managing postoperative/acute pain
- Patient-controlled analgesia (PCA) — IV morphine; set dose + lockout interval
- Epidural analgesia — superior for thoracic/abdominal surgery
Q26. Anatomical Basis of Enlarged Axillary Lymph Nodes
Groups of Axillary Lymph Nodes
| Group | Location | Drains |
|---|
| Lateral (brachial) | Medial to axillary vein | Upper limb |
| Pectoral (anterior) | Along lateral thoracic vessels; medial wall | Breast (lateral), chest wall, abdomen above umbilicus |
| Subscapular (posterior) | Along subscapular vessels; posterior wall | Posterior shoulder, back |
| Central | Fat of axilla, deep to pectoralis minor | Receives from all 3 groups above |
| Apical (infraclavicular) | Apex of axilla; medial to pectoralis minor | Receives from central group; drains to subclavian trunk |
Berg's Levels (for Breast Cancer Surgery)
| Level | Position relative to Pectoralis Minor |
|---|
| Level I | Lateral to lateral border of pectoralis minor |
| Level II | Behind/posterior to pectoralis minor |
| Level III | Medial to medial border (infraclavicular/apical group) |
Breast cancer spreads Level I → II → III (orderly progression — basis of SLNB)
Causes of Enlarged Axillary Lymph Nodes
Regional (draining area):
- Breast cancer — most important surgical cause; ipsilateral axillary LN metastasis
- Infections of upper limb, shoulder, chest wall (pyogenic, cat-scratch disease)
- Melanoma/SCC of ipsilateral upper limb
Systemic:
- Lymphoma (Hodgkin's / Non-Hodgkin's)
- Leukaemia
- Sarcoidosis
- HIV infection
- Infectious mononucleosis (EBV)
Clinical Significance
- Hard, fixed, matted nodes → malignancy
- Soft, tender, mobile → reactive/infective
- Sentinel Lymph Node Biopsy (SLNB): Preferred over ALND for early breast cancer; identifies first draining node; if negative → spares full dissection
- Rotter's nodes (interpectoral) — located between pectoralis major and minor; may be missed in standard axillary dissection
Q27. Anatomical Basis of Venepuncture of Cubital Veins
Anatomy of the Cubital Fossa
Boundaries:
- Lateral: Brachioradialis
- Medial: Pronator teres
- Base (superior): Imaginary line between medial and lateral epicondyles
- Roof: Deep fascia + bicipital aponeurosis + skin
Contents (lateral to medial: "TBNNMT"):
- Tendon of biceps brachii (central)
- Brachial artery (medial to tendon)
- Median nerve (medial to brachial artery)
- Radial nerve (lateral, in radial fossa)
Veins Used for Venepuncture
| Vein | Position | Notes |
|---|
| Median cubital vein | Crosses roof of cubital fossa obliquely; connects cephalic to basilic | Most commonly used for venepuncture and IV access — superficial, relatively fixed |
| Cephalic vein | Lateral aspect of forearm → antecubital fossa → deltopectoral groove → axillary vein | Preferred for long-term IV cannula/PICC lines — consistent anatomy |
| Basilic vein | Medial aspect of forearm → cubital fossa → arm → axillary vein | Deeper, less reliable; near medial cutaneous nerve of forearm |
Why the Bicipital Aponeurosis is Critical
- The bicipital aponeurosis runs from the biceps tendon medially to blend with the deep fascia
- It separates the superficial veins from the underlying brachial artery and median nerve
- During venepuncture: as long as the needle stays superficial to the bicipital aponeurosis, the brachial artery and median nerve are protected
- Danger: Excessive depth of needle → brachial artery puncture → haematoma, arterial thrombosis; median nerve injury
Clinical Points
- The median cubital vein is preferred for blood sampling (large calibre, relatively fixed)
- Cephalic vein is preferred for IV cannula insertion (less likely to be valved; no nearby nerves)
- Anatomical snuffbox veins (cephalic) used as alternative for IV access
- Femoral vein in cubital fossa region — not applicable; femoral venepuncture is at the femoral triangle
Q28. Anatomical Basis of Claw Hand
Definition
Claw hand (main en griffe) — a posture characterised by hyperextension at MCP joints and flexion at PIP and DIP joints of the ring and little fingers (and sometimes all four fingers).
Causative Nerve: Ulnar Nerve
Normal Function of Ulnar Nerve in the Hand
The ulnar nerve (C8, T1) supplies:
- All interossei (4 dorsal, 3 palmar)
- 3rd and 4th lumbricals (ring and little fingers)
- Hypothenar muscles
- Adductor pollicis
The Biomechanics
Normal position requires:
- MCP flexion — by interossei and lumbricals (intrinsic muscles)
- IP extension — by interossei acting via lateral bands of extensor expansion
After ulnar nerve injury:
- Interossei + 3rd/4th lumbricals LOST → no MCP flexion or IP extension via intrinsics
- Intact: Long flexors (FDP/FDS — median/ulnar) and long extensors (radial nerve)
- Net result: MCP hyperextension (by unopposed extensor digitorum) + IP flexion (by unopposed FDP/FDS)
- = Classic claw deformity
Why Mainly Ring and Little Fingers?
- Index and middle fingers have 1st and 2nd lumbricals supplied by the median nerve → partially compensated → less clawing
- Ring and little fingers rely on 3rd and 4th lumbricals (ulnar nerve) → more severe clawing
- = Ulnar paradox
Ulnar Paradox
- Low ulnar nerve lesion (at wrist) → more severe claw deformity (FDP intact → stronger IP flexion)
- High ulnar nerve lesion (at elbow) → less severe claw (FDP also paralysed → less IP flexion)
Other Causes of Claw Hand
| Cause | Notes |
|---|
| Ulnar nerve injury at wrist (Guyon's canal) | Claw of ring/little fingers only |
| Combined ulnar + median nerve injury | All four fingers clawed (T1 lesion) |
| Combined median + ulnar nerve injury | "Simian hand" — all intrinsics lost |
| Volkmann's ischaemic contracture | Forearm compartment syndrome → ischaemic fibrosis |
| Leprosy | Peripheral neuropathy → claw hand |
| Cervical rib (C8, T1 compression) | Similar to high ulnar injury |
Froment's Sign
- Ask patient to hold a piece of paper between thumb and index finger
- Ulnar nerve injury: Adductor pollicis weak → patient compensates by flexing FPL (median nerve) = flexed IP joint of thumb = positive Froment's sign
Q29. Infections of Fascial Spaces of Palm
Fascial Spaces of the Hand
The palm contains six potential spaces that can become infected:
| Space | Location | Access for Infection |
|---|
| Thenar space | Between 1st metacarpal and flexor tendons of index finger; anterior to adductor pollicis | Index finger/thumb flexor sheath |
| Midpalmar space | Deep to flexor tendons; between 3rd metacarpal and hypothenar fascia | Middle/ring finger sheaths |
| Hypothenar space | Between hypothenar fascia and 5th metacarpal | Little finger sheath |
| Interdigital (collar-button abscess) | Transverse distal palmar fascia — tracks both superficial and deep | Pressure necrosis through palmar fascia |
| Dorsal subaponeurotic space | Between extensor tendons and dorsal interossei | Direct inoculation |
| Space of Parona | Distal forearm, between pronator quadratus and flexor tendons | Extension from flexor sheath infections |
Collar-Button Abscess
- Dumbbell-shaped abscess: superficial component + deep component connected through a narrow isthmus in the palmar fascia
- Web space infections are the most common type
- Must drain both components
Clinical Features of Palmar Space Infection
- Painful, tense swelling of palm
- Dorsal oedema (often more marked than palmar swelling)
- Fingers held in partial flexion
- High fever, systemic toxicity
- Pointing — localises toward palmar aspect
Distinguishing thenar vs. midpalmar space:
- Thenar: swelling in thenar eminence; index finger held in extension/abduction; "ballooned thumb web"
- Midpalmar: loss of normal palmar concavity; ring/middle finger involvement
Spread
- Deep space infections can spread:
- Via lumbrical canals to web spaces (and vice versa)
- Into Space of Parona → forearm
- Via ulnar and radial bursae — "horseshoe abscess" (if both bursae involved)
Management
- IV antibiotics — broad-spectrum (Staph. aureus most common organism; cover MRSA if suspected): flucloxacillin ± metronidazole; vancomycin for MRSA
- Surgical Incision and Drainage (I&D) — definitive treatment
Incision for Thenar Space: Transverse incision in thumb web on palmar aspect (avoid digital nerves)
Incision for Midpalmar Space: Longitudinal incision between ring and middle finger (avoid neurovascular bundles); or transverse incision in distal palmar crease
Collar-Button Abscess: Both superficial AND deep components drained through palmar incision ± dorsal incision
- Post-drainage: irrigation, loose packing with gauze, elevation
- Physiotherapy early to prevent stiffness
- Repeat surgery if inadequate drainage
Q30. Important Muscle Groups of the Hand
Classification: Extrinsic vs. Intrinsic
A. Extrinsic Muscles (Origin in forearm; act on hand)
Flexors (Anterior Compartment of Forearm)
| Muscle | Nerve | Insertion | Action |
|---|
| FDS (Flexor Digitorum Superficialis) | Median nerve | Middle phalanges (digits 2–5) | Flex PIP joints |
| FDP (Flexor Digitorum Profundus) | Median (index/middle) + Ulnar (ring/little) | Distal phalanges (digits 2–5) | Flex DIP joints |
| FPL (Flexor Pollicis Longus) | Anterior interosseous (median) | Distal phalanx of thumb | Flex thumb IP joint |
Extensors (Posterior Compartment — Radial Nerve)
| Muscle | Action |
|---|
| Extensor Digitorum (EDC) | Extends MCP joints of fingers |
| Extensor Indicis (EI) | Independent index finger extension |
| Extensor Digiti Minimi (EDM) | Independent little finger extension |
| Extensor Pollicis Longus/Brevis | Extend thumb IP/MCP joints |
| Abductor Pollicis Longus | Abducts thumb at CMC joint |
The radial nerve has no intrinsic hand muscles — only extrinsic extensors and brachioradialis
B. Intrinsic Muscles (Origin AND insertion within the hand)
1. Thenar Muscles (Median Nerve, C8–T1 via recurrent branch)
Mnemonic: LOAF
| Muscle | Action |
|---|
| Lumbrical 1 & 2 | Flex MCP; extend IP of index and middle |
| Opponens Pollicis | Opposition of thumb (rotation + flexion at CMC) |
| Abductor Pollicis Brevis | Abducts thumb at MCP |
| Flexor Pollicis Brevis (superficial head) | Flexes thumb at MCP |
2. Hypothenar Muscles (Ulnar Nerve, C8–T1, deep branch)
| Muscle | Action |
|---|
| Abductor Digiti Minimi | Abducts little finger |
| Flexor Digiti Minimi | Flexes little finger at MCP |
| Opponens Digiti Minimi | Opposes little finger toward thumb |
3. Lumbricals (Four muscles)
| Lumbrical | Origin | Nerve |
|---|
| 1st and 2nd | Lateral two tendons of FDP | Median nerve |
| 3rd and 4th | Medial three tendons of FDP | Ulnar nerve (deep branch) |
Function: Flex MCP joints; extend IP joints (via lateral bands of extensor expansion)
4. Interossei
Dorsal Interossei (4) — DAB mnemonic: Dorsal ABduct
- Nerve: Ulnar (deep branch)
- Abduct fingers from the middle finger axis
- Also flex MCP and extend IP joints
Palmar Interossei (3) — PAD mnemonic: Palmar ADduct
- Nerve: Ulnar (deep branch)
- Adduct fingers toward the middle finger axis
5. Adductor Pollicis
- Nerve: Ulnar (deep branch)
- Two heads (oblique + transverse)
- Adducts thumb toward palm
- Tested by Froment's sign
Summary Table — Nerve Supply of Hand Muscles
| Nerve | Intrinsic Muscles Supplied |
|---|
| Median | Thenar (LOAF) + Lumbricals 1 & 2 |
| Ulnar | All interossei + Lumbricals 3 & 4 + Hypothenar + Adductor pollicis |
| Radial | None (no intrinsic hand muscles) |
"All intrinsic hand muscles are either median or ulnar nerve. Radial nerve = zero intrinsic hand muscles."
Quick Reference Summary
| Q | Key Mnemonic/Point |
|---|
| 17 | Thyroid swellings: iodine deficiency → ↑TSH → goitre; Graves' = TSI antibodies; Hashimoto's = CD8+ T cells |
| 18 | Superior parathyroid = 4th pouch, dorsal to RLN; Inferior = 3rd pouch, ventral to RLN |
| 19 | HPT = "Bones, Stones, Groans, Moans"; HPT acute → IV saline + furosemide + bisphosphonates; Hypo → IV Ca gluconate |
| 20 | Right adrenal vein → IVC (short, dangerous); Left → left renal vein; GFR = ACE (zones & products) |
| 21 | Audit cycle: Plan → Collect → Analyse → Benchmark → Feedback → Act → Re-audit |
| 22 | Healing phases: Haemostasis → Inflammation (PMN→Macrophage) → Proliferation (granulation tissue) → Remodelling; max strength 70–80% |
| 23 | Yellow bag = infectious waste → incineration; Red bag = microbiological → autoclave; Sharps → puncture-proof → incineration |
| 24 | Ethics pillars: Autonomy, Beneficence, Non-maleficence, Justice; Informed consent = Voluntary + Informed + Capacity + Authorisation |
| 25 | GA triad: Hypnosis + Analgesia + Relaxation; MAC = potency measure; WHO ladder; Multimodal analgesia = gold standard |
| 26 | 5 axillary LN groups; Level I/II/III relative to pectoralis minor; breast spreads Level I→II→III; SLNB preferred |
| 27 | Median cubital vein best for venepuncture; bicipital aponeurosis protects brachial artery + median nerve below |
| 28 | Ulnar nerve loss → interossei + 3rd/4th lumbrical lost → MCP hyperextension + IP flexion = claw; Ulnar paradox = low lesion worse |
| 29 | Thenar + midpalmar + hypothenar + web (collar-button) + Space of Parona; treatment = IV antibiotics + surgical I&D |
| 30 | Median = LOAF + Lumbricals 1&2; Ulnar = all interossei + Lumb 3&4 + hypothenar + adductor pollicis; Radial = no intrinsics; DAB/PAD for interossei |
| # | Topic | Key Takeaway |
|---|
| 17 | Etiopathogenesis of thyroidal swellings | ↓ Iodine → ↑ TSH → goitre; Graves' = TSI antibodies; Hashimoto's = CD8+ T cells; BRAF in papillary Ca |
| 18 | Applied anatomy of parathyroid | Superior = 4th pouch, dorsal to RLN; Inferior = 3rd pouch, ventral to RLN; both supplied by inferior thyroid artery |
| 19 | Hypo & Hyperparathyroidism + management | HPT = "Bones, Stones, Groans, Moans"; Acute HPT → IV saline + furosemide + bisphosphonates; Hypo → IV Ca gluconate → oral Ca + calcitriol |
| 20 | Applied anatomy of adrenal gland | Right adrenal vein → IVC directly (short, dangerous); Left → left renal vein; GFR = ACE (zones & products); cortex = mesoderm, medulla = neural crest |
| 21 | Planning and conduct of surgical audit | Audit cycle: Plan → Collect → Risk-adjust → Benchmark → Feedback → Act → Re-audit; ACS-NSQIP = gold standard tool |
| 22 | Tissue injuries and management | 4 phases of healing; max tensile strength only 70–80%; keloid = beyond wound borders; multimodal chronic wound management |
| 23 | Biohazard & hospital waste disposal | Yellow = infectious → incineration; Red = microbiological → autoclave; Sharps → puncture-proof containers → incineration |
| 24 | Principles of ethics in surgery | 4 pillars: Autonomy, Beneficence, Non-maleficence, Justice; Informed consent = Voluntary + Informed + Capacity + Authorisation |
| 25 | Anaesthesia and pain management | GA triad: hypnosis + analgesia + relaxation; WHO analgesic ladder; multimodal analgesia = gold standard postoperatively |
| 26 | Anatomical basis of enlarged axillary LNs | 5 groups; Berg's Levels I–III relative to pectoralis minor; breast cancer spreads Level I→II→III; SLNB preferred |
| 27 | Anatomical basis of cubital vein venepuncture | Median cubital vein preferred; bicipital aponeurosis protects brachial artery + median nerve below it |
| 28 | Anatomical basis of claw hand | Ulnar nerve injury → loss of interossei + 3rd/4th lumbricals → MCP hyperextension + IP flexion; ulnar paradox; Froment's sign |
| 29 | Infections of fascial spaces of palm | 6 spaces; collar-button abscess = dumbbell shape; Staph. aureus; treatment = IV antibiotics + surgical I&D |
| 30 | Important muscle groups of hand | Median = LOAF + Lumbricals 1&2; Ulnar = all interossei + Lumb 3&4 + hypothenar + adductor pollicis; Radial = NO intrinsics; DAB = dorsal abduct; PAD = palmar adduct |